Systems biology of cisplatin resistance: past, present and future

The platinum derivative cis-diamminedichloroplatinum(II), best known as cisplatin, is currently employed for the clinical management of patients affected by testicular, ovarian, head and neck, colorectal, bladder and lung cancers. For a long time, the antineoplastic effects of cisplatin have been fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Galluzzi, L, Vitale, I, Michels, J, Brenner, C, Szabadkai, G, Harel-Bellan, A, Castedo, M, Kroemer, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047912/
https://www.ncbi.nlm.nih.gov/pubmed/24874729
http://dx.doi.org/10.1038/cddis.2013.428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047912/
https://www.ncbi.nlm.nih.gov/pubmed/24874729
http://dx.doi.org/10.1038/cddis.2013.428

Ejemplares similares